Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016643
Filing Date
2022-08-11
Accepted
2022-08-11 07:30:52
Documents
73
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sldb-20220630.htm   iXBRL 10-Q 2945554
2 EX-10.1 sldb-ex10_1.htm EX-10.1 29534
3 EX-31.1 sldb-ex31_1.htm EX-31.1 18824
4 EX-31.2 sldb-ex31_2.htm EX-31.2 18836
5 EX-32.1 sldb-ex32_1.htm EX-32.1 11847
6 EX-32.2 sldb-ex32_2.htm EX-32.2 11879
  Complete submission text file 0000950170-22-016643.txt   8519388

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sldb-20220630_cal.xml EX-101.CAL 41652
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sldb-20220630_pre.xml EX-101.PRE 250733
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sldb-20220630.xsd EX-101.SCH 47656
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sldb-20220630_lab.xml EX-101.LAB 339279
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sldb-20220630_def.xml EX-101.DEF 115695
67 EXTRACTED XBRL INSTANCE DOCUMENT sldb-20220630_htm.xml XML 1490522
Mailing Address 500 RUTHERFORD AVENUE CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38360 | Film No.: 221153701
SIC: 2836 Biological Products, (No Diagnostic Substances)